Media & Press Releases

Manufacturers of cell- and tissue-based products are constantly striving to find the right balance between assuring sterility and ensuring cell- and tissue-based products retain their respective viability and functionality. Alternative testing...

Traditional automatic visual inspection (AVI) can yield false rejections up to 20 percent, by some estimates, and “sometimes even more,” according to Jorge Delgado. Delgado, a Process Development Scientific Director at Amgen, is exploring how false...

Teleoperated robots, which are remotely operated, can provide flexibility to operators when automation or isolators won’t suffice. Jean-Maxime Guay, Pfizer Senior Manager of Manufacturing Intelligence with Pfizer Canada, discusses how Pfizer is...

The 2025 ISPE Biotechnology Conference will take place 2 – 3 June in Boston, Massachusetts, USA and virtually ISPE has announced its keynote speakers at the 2025 ISPE Biotechnology Conference, taking place Monday, 2 June, through Tuesday, 3 June, in...

Vivianne Arencibia, Vice Chair of the ISPE International Board of Directors and Vice President of Global Quality Systems and Compliance at Moderna, shares her journey in the pharmaceutical industry in a recent interview with Bizwomen. She discusses...

The greatest barrier to digital maturity is an inadequate company culture, according to findings from an ISPE survey. In an interview with Bioprocess Online, Malcolm Jeffers with the International Academy of Automation Engineering addresses the ISPE...

The 2025 ISPE Aseptic Conference will take place 17-18 March in Washington, D.C., United States and virtually. ISPE has announced planned featured speakers for the 2025 ISPE Aseptic Conference, taking place Monday, 17 March, through Tuesday, 18 March...

ISPE would like to thank the 2024–2025 ISPE International Board of Directors for their contributions thus far. This includes the recent addition of David Churchward, who has been appointed as the Secretary of the 2024-2025 ISPE International Board of...

Simon Capewell, Head of Operational Technology and Digital Solutions at AstraZeneca’s APICOM facility, discussed construction plans in process for the facility ahead of the 2024 ISPE Pharma 4.0TM and Annex 1 Conference in December. Capewell shared...

Chris Grail, Bayer Pharmaceutical's engineering and maintenance excellence lead, shared insights on his company’s digitalization efforts ahead of the 2024 ISPE Pharma 4.0™ and Annex 1 Conference in December. Grail discussed how Bayer is orchestrating...